Market Overview

Bionano Genomics Wins Contract, Stock Up 50%

Bionano Genomics Wins Contract, Stock Up 50%

Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading higher after the company announced on Thursday that Novogene has adopted the Saphyr system for genome imaging and incorporated it into their expansive repertoire of genome analysis technology services.

“We believe the addition of Bionano technology could enable Novogene's global customers to achieve comprehensive analysis of platinum genome assembly, and genome structure, including highly accurate detection of genomic structural variations that remain unresolved by current next-generation sequencing (NGS) technology and other methods," the company said in a statement.

Bionano Genomics shares were trading up 45.72% at $1.31 in Thursday’s pre-market session. The stock has a 52-week high of $8 and a 52-week low of 50 cents.

Posted-In: News Penny Stocks Contracts Markets


Related Articles (BNGO)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

McDermott's Lummus Wins Petrochemicals Contract In China

The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs